Platelet release products modulate some aspects of polymorphonuclear leukocyte activation
暂无分享,去创建一个
[1] M. Kazatchkine,et al. Platelet‐dependent induction and amplification of polymorphonuclear leucocyte lysosomal enzyme release , 1989, British journal of haematology.
[2] A. Offidani,et al. Changes in membrane properties of erythrocytes and polymorphonuclear cells in psoriasis. , 1989, Biochemical medicine and metabolic biology.
[3] M. Baggiolini,et al. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils. , 1989, Biochemical and biophysical research communications.
[4] A. Stephenson,et al. Inhibition of Neutrophil Superoxide Anion Generation by Platelet Products: Role of Adenine Nucleotides , 1988, Journal of leukocyte biology.
[5] B. Zweiman,et al. Platelet Activating Factor Increases Expression of Complement Receptors on Human Neutrophils , 1988, Journal of leukocyte biology.
[6] S. McGarrity,et al. Inhibition of Neutrophil Functions by Platelets and Platelet‐Derived Products: Description of Multiple Inhibitory Properties , 1988, Journal of leukocyte biology.
[7] F. Silveri,et al. Stimulated chemiluminescence of polymorphonuclear leukocytes in rheumatoid arthritis: in vivo enhancement by auranofin. , 1988, Zeitschrift fur Rheumatologie.
[8] Stefan Fischer,et al. Platelet-neutrophil interactions. (12S)-hydroxyeicosatetraen-1,20-dioic acid: a new eicosanoid synthesized by unstimulated neutrophils from (12S)-20-dihydroxyeicosatetraenoic acid. , 1988, The Journal of biological chemistry.
[9] P. Ward,et al. Platelet enhancement of O2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[10] S. Muti,et al. [Free oxygen radicals. Their role in the physiopathology of rheumatic diseases and therapeutic implications]. , 1987, La Clinica terapeutica.
[11] R. Verwilghen,et al. Platelets augment granulocyte aggregation and cytotoxicity: uncovering of their effects by improved cell separation techniques using Percoll gradients. , 2009, Scandinavian journal of haematology.
[12] R. Fiorini,et al. Changes of membrane fluidity in chemotactic peptide-stimulated polymorphonuclear leukocytes. , 1986, Biochemical and biophysical research communications.
[13] F. Rossi. The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. , 1986, Biochimica et biophysica acta.
[14] J. Pincemail,et al. [Toxicity of oxygen, free radicals and defense mechanisms]. , 1986, Presse medicale.
[15] C. Bronner,et al. Plasma membrane fluidity measurements on whole living cells by fluorescence anisotropy of trimethylammoniumdiphenylhexatriene. , 1985, Biochimica et biophysica acta.
[16] Berger,et al. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. , 1984, The Journal of clinical investigation.
[17] R. Senior,et al. Platelet-derived growth factor promotes polymorphonuclear leukocyte activation. , 1984, Blood.
[18] E. Bonvini,et al. Activation of the oxidative burst in human monocytes is associated with inhibition of methionine-dependent methylation of neutral lipids and phospholipids. , 1984, The Journal of clinical investigation.
[19] D. Fearon,et al. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. , 1983, Journal of immunology.
[20] G. Weissmann,et al. The effect of various stimuli and calcium antagonists on the fluorescence response of chlorotetracycline-loaded human neutrophils. , 1982, Biochimica et biophysica acta.
[21] G. Weissmann,et al. The roles of extracellular and intracellular calcium in lysosomal enzyme release and superoxide anion generation by human neutrophils. , 1981, Biochimica et biophysica acta.
[22] J. Lukens,et al. Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides. , 1981, Journal of immunology.
[23] J. Lunec,et al. Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. , 1981, The Journal of rheumatology.
[24] M. Shinitzky,et al. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[25] T. Molski,et al. Calmodulin inhibitors block neutrophil degranulation at a step distal from the mobilization of calcium. , 1980, Biochemical and biophysical research communications.
[26] F. Hirata,et al. Phospholipid methylation and biological signal transmission. , 1980, Science.
[27] G. Weissmann,et al. Release of inflammatory mediators from stimulated neutrophils. , 1980, The New England journal of medicine.
[28] M. Shinitzky,et al. Modulation of Transferrin Receptors in Bone Marrow Cells by Changes in Lipid Fluidity , 1979, British journal of haematology.
[29] P. Henkart,et al. Fluidity of cell membranes--current concepts and trends. , 1979, International review of cytology.
[30] I. Bonta,et al. Plasma levels of malondialdehyde, a product of cyclo-oxygenase-dependent and independent lipid peroxidation in rheumatoid arthritis: a correlation with disease activity. , 1979, Prostaglandins and medicine.
[31] J. Metcalf,et al. H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. , 1977, The Journal of clinical investigation.
[32] P. McCay,et al. Evidence that peroxidation of lysosomal membranes is initiated by hydroxyl free radicals produced during flavin enzyme activity. , 1973, The Journal of biological chemistry.